Stimuli‐Sensitive Nanotherapies for the Treatment of Osteoarthritis

Z Wang, S Wang, K Wang, X Wu… - Macromolecular …, 2021 - Wiley Online Library
Osteoarthritis (OA) is a common chronic inflammatory disease in the joints. It is one of the
leading causes of disability with increasing morbidity, which has become one of the serious …

Stimuli-responsive polymeric nanomaterials for rheumatoid arthritis therapy

Y Xie, RG Tuguntaev, C Mao, H Chen, Y Tao… - Biophysics Reports, 2020 - Springer
Rheumatoid arthritis (RA) is a long-term inflammatory disease derived from an autoimmune
disorder of the synovial membrane. Current therapeutic strategies for RA mainly aim to …

Stimulus‐Responsive Drug Delivery Nanoplatforms for Osteoarthritis Therapy

Q Jiang, S Zhang - Small, 2023 - Wiley Online Library
Osteoarthritis (OA) is one of the most prevalent age‐related degenerative diseases. With an
increasingly aging global population, greater numbers of OA patients are providing clear …

Nanomaterials for the local and targeted delivery of osteoarthritis drugs

P Chinnagounder Periyasamy… - Journal of …, 2012 - Wiley Online Library
Nanotechnology has found its potential in every possible field of science and engineering. It
offers a plethora of options to design tools at the nanometer scale, which can be expected to …

Targeted treatment for osteoarthritis: drugs and delivery system

L Mao, W Wu, M Wang, J Guo, H Li, S Zhang, J Xu… - Drug …, 2021 - Taylor & Francis
The management of osteoarthritis (OA) is a clinical challenge due to the particular avascular,
dense, and occluded tissue structure. Despite numerous clinical reports and animal studies …

Recent advances in nano-therapeutic strategies for osteoarthritis

X Guo, J Lou, F Wang, D Fan, Z Qin - Frontiers in Pharmacology, 2022 - frontiersin.org
Osteoarthritis (OA) is the most common type of arthritis and the leading cause of disability
globally. It tends to occur in middle age or due to an injury or obesity. OA occurs with the …

[HTML][HTML] Advanced application of stimuli-responsive drug delivery system for inflammatory arthritis treatment

M Zhang, W Hu, C Cai, Y Wu, J Li, S Dong - Materials Today Bio, 2022 - Elsevier
Inflammatory arthritis is a major cause of disability in the elderly. This condition causes joint
pain, loss of function, and deterioration of quality of life, mainly due to osteoarthritis (OA) and …

New insights in osteoarthritis diagnosis and treatment: Nano‐strategies for an improved disease management

M Paesa, T Alejo, F Garcia‐Alvarez… - Wiley …, 2023 - Wiley Online Library
Osteoarthritis (OA) is a common chronic joint pathology that has become a predominant
cause of disability worldwide. Even though the origin and evolution of OA rely on different …

Bio-responsive and multi-modality imaging nanomedicine for osteoarthritis theranostics

S Xue, G Ruan, J Li, H Madry, C Zhang, C Ding - Biomaterials Science, 2023 - pubs.rsc.org
Osteoarthritis (OA) is one of the most common joint diseases currently, characterized by the
gradual degradation of cartilage, remodeling of subchondral bone, development of synovitis …

Nanotherapeutic approaches for the treatment of rheumatoid arthritis

CTN Pham - Wiley Interdisciplinary Reviews: Nanomedicine …, 2011 - Wiley Online Library
Rheumatoid arthritis (RA) is a common inflammatory disease characterized by progressive
bone and cartilage destruction, resulting in severe functional limitations, shortened lifespan …